These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement. Muneretto C, Bisleri G, Moggi A, Di Bacco L, Tespili M, Repossini A, Rambaldini M. Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140 [Abstract] [Full Text] [Related]
12. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). Hahn RT, Pibarot P, Webb J, Rodes-Cabau J, Herrmann HC, Williams M, Makkar R, Szeto WY, Main ML, Thourani VH, Tuzcu EM, Kapadia S, Akin J, McAndrew T, Xu K, Leon MB, Kodali SK. JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022 [Abstract] [Full Text] [Related]
13. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis. Kamperidis V, van Rosendael PJ, de Weger A, Katsanos S, Regeer M, van der Kley F, Mertens B, Sianos G, Ajmone Marsan N, Bax JJ, Delgado V. JACC Cardiovasc Interv; 2015 Apr 27; 8(5):670-7. PubMed ID: 25946438 [Abstract] [Full Text] [Related]
14. Incidence, Predictive Factors, and Effect of Delirium After Transcatheter Aortic Valve Replacement. Abawi M, Nijhoff F, Agostoni P, Emmelot-Vonk MH, de Vries R, Doevendans PA, Stella PR. JACC Cardiovasc Interv; 2016 Jan 25; 9(2):160-8. PubMed ID: 26793958 [Abstract] [Full Text] [Related]
15. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. Piazza N, Kalesan B, van Mieghem N, Head S, Wenaweser P, Carrel TP, Bleiziffer S, de Jaegere PP, Gahl B, Anderson RH, Kappetein AP, Lange R, Serruys PW, Windecker S, Jüni P. JACC Cardiovasc Interv; 2013 May 25; 6(5):443-51. PubMed ID: 23702009 [Abstract] [Full Text] [Related]
16. Major thrombocytopenia after balloon-expandable transcatheter aortic valve replacement: prognostic implications and comparison to surgical aortic valve replacement. Jilaihawi H, Doctor N, Chakravarty T, Kashif M, Mirocha J, Cheng W, Lill M, Nakamura M, Gheorghiu M, Makkar RR. Catheter Cardiovasc Interv; 2015 Jan 01; 85(1):130-7. PubMed ID: 24677617 [Abstract] [Full Text] [Related]
17. Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis. Thakkar B, Patel A, Mohamad B, Patel NJ, Bhatt P, Bhimani R, Patel A, Arora S, Savani C, Solanki S, Sonani R, Patel S, Patel N, Deshmukh A, Mohamad T, Grines C, Cleman M, Mangi A, Forrest J, Badheka AO. Catheter Cardiovasc Interv; 2016 Apr 01; 87(5):955-62. PubMed ID: 26699085 [Abstract] [Full Text] [Related]
18. Long-term outcomes associated with the transaortic approach to transcatheter Aortic valve replacement. Lardizabal JA, Macon CJ, O'Neill BP, Desai H, Singh V, Martinez CA, Alfonso CE, Cohen MG, Heldman AW, O'Neill WW, Williams DB. Catheter Cardiovasc Interv; 2015 Jun 01; 85(7):1226-30. PubMed ID: 25511236 [Abstract] [Full Text] [Related]
19. Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement. Paknikar R, Friedman J, Cron D, Deeb GM, Chetcuti S, Grossman PM, Wang S, Englesbe M, Patel HJ. J Thorac Cardiovasc Surg; 2016 Mar 01; 151(3):745-751. PubMed ID: 26896357 [Abstract] [Full Text] [Related]
20. Hemodynamic performance and outcome of percutaneous versus surgical stentless bioprostheses for aortic stenosis with anticipated patient-prosthesis mismatch. Finkelstein A, Schwartz AL, Uretzky G, Banai S, Keren G, Kramer A, Topilsky Y. J Thorac Cardiovasc Surg; 2014 Jun 01; 147(6):1892-9. PubMed ID: 23993320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]